Prospective feasible study to evaluate neoadjuvant chemoradiotherapy for locally advanced rectal Cancer (Neoadjuvant-synchronus TS1+RT)

Prospective feasible study to evaluate neoadjuvant chemoradiotherapy for locally advanced rectal Cancer (Neoadjuvant-synchronus TS1+RT) - Prospective feasible study to evaluate neoadjuvant chemoradiotherapy for rectal cancer

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000003396

Enrollment

Registered

2010-03-29

Start date

2009-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

rectal cancer

Interventions

Rectal resection after neoadjuvant chemoradio therapy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Rectal cancer (Ra, Rb, P) diagnosed as adenocarcinoma pathologically, and preoperative diagnosed as T3/T4, N0-3.

Exclusion criteria

Exclusion criteria: Cases that have critical drug sensitivity to TS-1 or multiple cancers, multiple colorectal cancer with activity.

Design outcomes

Primary

Measure	Time frame
Rate of complete treatment	—

Secondary

Measure	Time frame
safety, pathological evaluation, rate of curative resection, response rate	—

Countries

Japan

Contacts

Public ContactMasafumi Inomata

Oita University faculty of medicine Surgery I

geka1@oita-u.ac.jp097-586-5843

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026